Possible Benefit of Angiotensin II Receptor Blockers in COVID-19 Patients: A Case Series

Figure 1

Angiotensin II, C-reactive protein, and interleukin-6 levels over time in case 1 (a), case 2 (b), case 3 (c), and case 4 (d).

(a)

(b)

(c)

(d)